Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) EBT Margin (2017 - 2025)

Historic EBT Margin for Assembly Biosciences (ASMB) over the last 8 years, with Q3 2025 value amounting to 85.23%.

  • Assembly Biosciences' EBT Margin rose 552000.0% to 85.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 103.85%, marking a year-over-year increase of 386500.0%. This contributed to the annual value of 139.72% for FY2024, which is 7146000.0% up from last year.
  • Latest data reveals that Assembly Biosciences reported EBT Margin of 85.23% as of Q3 2025, which was up 552000.0% from 105.94% recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' EBT Margin registered a high of 85.23% during Q3 2025, and its lowest value of 300.66% during Q3 2021.
  • Moreover, its 4-year median value for EBT Margin was 140.44% (2024), whereas its average is 144.76%.
  • In the last 5 years, Assembly Biosciences' EBT Margin plummeted by -2909800bps in 2021 and then skyrocketed by 632900bps in 2025.
  • Quarter analysis of 4 years shows Assembly Biosciences' EBT Margin stood at 300.66% in 2021, then skyrocketed by 49bps to 152.58% in 2023, then rose by 7bps to 141.51% in 2024, then surged by 40bps to 85.23% in 2025.
  • Its EBT Margin stands at 85.23% for Q3 2025, versus 105.94% for Q2 2025 and 93.62% for Q1 2025.